| - GRCh37:
- Chr5:225544-225545
- GRCh38:
- Chr5:225429-225430
| SDHA | A109fs | Paragangliomas 5 | Pathogenic (Jan 19, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235257
- GRCh38:
- Chr5:235142
| SDHA | | Paragangliomas 5 | Likely pathogenic (Jan 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228314-228315
- GRCh38:
- Chr5:228199-228200
| SDHA | T165fs, T213fs | Paragangliomas 5 | Pathogenic (Jan 10, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224472
- GRCh38:
- Chr5:224357
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 27, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228394
- GRCh38:
- Chr5:228279
| SDHA | I191R, I239R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Sep 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226174
- GRCh38:
- Chr5:226059
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225997
- GRCh38:
- Chr5:225882
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224596
- GRCh38:
- Chr5:224481
| SDHA | T91I | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226086
- GRCh38:
- Chr5:225971
| SDHA | K182R, K134R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228435
- GRCh38:
- Chr5:228320
| SDHA | V205L, V253L | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Aug 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240501
- GRCh38:
- Chr5:240386
| SDHA | N487K, N439K | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225983
- GRCh38:
- Chr5:225868
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (May 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235246-235247
- GRCh38:
- Chr5:235131-235132
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240493
- GRCh38:
- Chr5:240378
| SDHA | K485Q, K437Q | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Sep 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:256436-256438
- GRCh38:
- Chr5:256321-256323
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223595
- GRCh38:
- Chr5:223480
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely pathogenic (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251198
- GRCh38:
- Chr5:251083
| SDHA | H548R, H500R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225689
- GRCh38:
- Chr5:225574
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233705
- GRCh38:
- Chr5:233590
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (May 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226033
- GRCh38:
- Chr5:225918
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235251
- GRCh38:
- Chr5:235136
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Oct 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226072
- GRCh38:
- Chr5:225957
| SDHA | S177R, S129R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Dec 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr5:218523
- GRCh38:
- Chr5:218408
| SDHA | L18Q | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226007
- GRCh38:
- Chr5:225892
| SDHA | Y156H, Y108H | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224652
- GRCh38:
- Chr5:224537
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223697
- GRCh38:
- Chr5:223582
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jul 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235400
- GRCh38:
- Chr5:235285
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:236578
- GRCh38:
- Chr5:236463
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228395
- GRCh38:
- Chr5:228280
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jul 23, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228371
- GRCh38:
- Chr5:228256
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224473
- GRCh38:
- Chr5:224358
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely pathogenic (Aug 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:218524
- GRCh38:
- Chr5:218409
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240466
- GRCh38:
- Chr5:240351
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:231062
- GRCh38:
- Chr5:230947
| SDHA | T281S, T233S | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240458
- GRCh38:
- Chr5:240343
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Benign (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:256462
- GRCh38:
- Chr5:256347
| SDHA | Y593C, Y560C, Y641C | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jun 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251598
- GRCh38:
- Chr5:251483
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:218546
- GRCh38:
- Chr5:218431
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:256434
- GRCh38:
- Chr5:256319
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224654
- GRCh38:
- Chr5:224539
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235355
- GRCh38:
- Chr5:235240
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251508
- GRCh38:
- Chr5:251393
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233619
- GRCh38:
- Chr5:233504
| SDHA | T308K, T260K | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251194
- GRCh38:
- Chr5:251079
| SDHA | K499Q, K547Q | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233759
- GRCh38:
- Chr5:233644
| SDHA | R355*, R307* | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224459
- GRCh38:
- Chr5:224344
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228300
- GRCh38:
- Chr5:228185
| SDHA | S160P, S208P | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225622
- GRCh38:
- Chr5:225507
| SDHA | G134V | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (May 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224483
- GRCh38:
- Chr5:224368
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Jun 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224460
- GRCh38:
- Chr5:224345
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235472
- GRCh38:
- Chr5:235357
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Oct 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224457
- GRCh38:
- Chr5:224342
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240603
- GRCh38:
- Chr5:240488
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:231081
- GRCh38:
- Chr5:230966
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225620
- GRCh38:
- Chr5:225505
| SDHA | D135fs | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (May 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224607
- GRCh38:
- Chr5:224492
| SDHA | P95A | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jul 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233758
- GRCh38:
- Chr5:233643
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (May 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240602
- GRCh38:
- Chr5:240487
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (May 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228387
- GRCh38:
- Chr5:228272
| SDHA | L189V, L237V | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251170
- GRCh38:
- Chr5:251055
| SDHA | I539V, I491V | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:218471-218472
- GRCh38:
- Chr5:218356-218357
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (May 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251181
- GRCh38:
- Chr5:251066
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (May 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223580
- GRCh38:
- Chr5:223465
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225668
- GRCh38:
- Chr5:225553
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235277
- GRCh38:
- Chr5:235162
| SDHA | K361N, K313N | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240533
- GRCh38:
- Chr5:240418
| SDHA | K498T, K450T | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:236602
- GRCh38:
- Chr5:236487
| SDHA | E392D, E440D | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223604
- GRCh38:
- Chr5:223489
| SDHA | T24R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jul 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228429
- GRCh38:
- Chr5:228314
| SDHA | N251D, N203D | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235326-235327
- GRCh38:
- Chr5:235211-235212
| SDHA | R331fs, R379fs | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (Jun 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240505-240507
- GRCh38:
- Chr5:240390-240392
| SDHA | G441del, G489del | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Aug 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224585
- GRCh38:
- Chr5:224470
| SDHA | | Hereditary cancer-predisposing syndrome, Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1
| Likely benign (Feb 20, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr5:240458
- GRCh38:
- Chr5:240343
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251228
- GRCh38:
- Chr5:251113
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223671
- GRCh38:
- Chr5:223556
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240476-240477
- GRCh38:
- Chr5:240361-240362
| SDHA | K432fs, K480fs | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251119
- GRCh38:
- Chr5:251004
| SDHA | H522Y, H474Y | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:236662
- GRCh38:
- Chr5:236547
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251601
- GRCh38:
- Chr5:251486
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Mar 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223675
- GRCh38:
- Chr5:223560
| SDHA | S48T | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233590
- GRCh38:
- Chr5:233475
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely pathogenic (Mar 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225550
- GRCh38:
- Chr5:225435
| SDHA | A110V | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235333
- GRCh38:
- Chr5:235218
| SDHA | L332R, L380R | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235376
- GRCh38:
- Chr5:235261
| SDHA | D346E, D394E | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:236524
- GRCh38:
- Chr5:236409
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Sep 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:225562
- GRCh38:
- Chr5:225447
| SDHA | M114K | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Mar 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:226015
- GRCh38:
- Chr5:225900
| SDHA | M158I, M110I | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Apr 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:240524
- GRCh38:
- Chr5:240409
| SDHA | N447I, N495I | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:235472-235473
- GRCh38:
- Chr5:235357-235358
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Benign (Apr 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:231100
- GRCh38:
- Chr5:230985
| SDHA | Q294K, Q246K | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Feb 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224627
- GRCh38:
- Chr5:224512
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Feb 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223664
- GRCh38:
- Chr5:223549
| SDHA | S44C | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Feb 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:228343
- GRCh38:
- Chr5:228228
| SDHA | L174S, L222S | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224529
- GRCh38:
- Chr5:224414
| SDHA | A69S | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Feb 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:223677
- GRCh38:
- Chr5:223562
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Aug 13, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251155
- GRCh38:
- Chr5:251040
| SDHA | E486K, E534K | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Feb 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224544
- GRCh38:
- Chr5:224429
| SDHA | | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Likely benign (Feb 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:233718
- GRCh38:
- Chr5:233603
| SDHA | D341G, D293G | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:224526
- GRCh38:
- Chr5:224411
| SDHA | G68S | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Uncertain significance (Jan 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr5:251163
- GRCh38:
- Chr5:251048
| SDHA | C536*, C488* | Paragangliomas 5, Mitochondrial complex II deficiency, nuclear type 1 | Pathogenic (Apr 3, 2022) | criteria provided, single submitter |